Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other financing activities (2018 - 2025)

Historic Other financing activities for Collegium Pharmaceutical (COLL) over the last 3 years, with Q3 2025 value amounting to $964000.0.

  • Collegium Pharmaceutical's Other financing activities rose 57887.32% to $964000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 2313.45%. This contributed to the annual value of -$16000.0 for FY2015, which is N/A changed from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Other financing activities stood at $964000.0, which was up 57887.32% from $428000.0 recorded in Q2 2025.
  • Collegium Pharmaceutical's Other financing activities' 5-year high stood at $5.9 million during Q2 2024, with a 5-year trough of $142000.0 in Q3 2024.